1-2 of 2
Nadja Jäkel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Dose Reduced Chemotherapy in Sequence with Blinatumomab for Newly Diagnosed Older Patients with Ph/BCR::ABL Negative B-Precursor Adult Lymphoblastic Leukemia (ALL): Preliminary Results of the GMALL Bold Trial

Nicola Goekbuget, Stefan Schwartz, Christoph Faul, Max S. Topp, Marion Subklewe, Andrea Renzelmann, Andrea Stoltefuss, Bernd Hertenstein, Anne Wilke, Simon Raffel, Nadja Jäkel, Vladan Vucinic, Dirk Markus Niemann, Lena Reiser, Hubert Serve, Monika Brüggemann, Andreas Viardot
Journal: Blood
Blood (2023) 142 (Supplement 1): 964.
https://doi.org/10.1182/blood-2023-180472
Published: 2023
Journal Articles

The Use of Erythropoietic-Stimulating Agents (ESAs) with Ruxolitinib in Patients with Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), and Post-Essential Thrombocythemia Myelofibrosis (PET-MF).

Mary Frances McMullin, MD, Claire N Harrison, DM FRCP FRCPath, Dietger Niederwieser, Hilde Demuynck, Nadja Jakel, Andres Sirulnik, MD, PhD, Mari McQuity, RN, MPH, Viktoriya Stalbovskaya, PhD, Christian Recher, MD, Koen Theunissen, MD, Heinz Gisslinger, MD, Jean-Jacques Kiladjian, MD, PhD, Haifa-Kathrin Al- Ali
Journal: Blood
Blood (2012) 120 (21): 2838.
https://doi.org/10.1182/blood.V120.21.2838.2838
Published: 2012